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Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has resulted in an urgent need to
understand the pathophysiology of SARS-CoV2 infection, to assist in the identification of treatment strategies. Viral
tissue tropism is an active area of investigation, one approach to which is identification of virus within tissues by
electron microscopy of post-mortem and surgical specimens. Most diagnostic histopathologists have limited under-
standing of the ultrastructural features of normal cell trafficking pathways, which can resemble intra- and extracel-
lular coronavirus; in addition, viral replication pathways make use of these trafficking pathways. Herein, we review
these pathways and their ultrastructural appearances, with emphasis on structures which may be confused with coro-
navirus. In particular, we draw attention to the fact that, when using routine fixation and processing, the typical
‘crown’ that characterises a coronavirus is not readily identified on intracellular virions, which are located in
membrane-bound vacuoles. In addition, the viral nucleocapsid is seen as black dots within the virion and is more dis-
criminatory in differentiating virions from other cellular structures. The identification of the viral replication organ-
elle, a collection of membranous structures (convoluted membranes) seen at a relatively low scanning power, may
help to draw attention to infected cells, which can be sparse.
© 2020 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great
Britain and Ireland.
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Introduction
In the wake of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) pandemic, clinicians and
scientists from around the world havemobilised technol-
ogies old and new to bring light to the pathophysiology
underpinning the many clinical manifestations of infec-
tion, collectively referred to as COVID-19 (coronavirus
disease 2019). Clinical presentations are of varying
severity, from asymptomatic to life-threatening, and
often affect multiple organs. We do not yet fully know
how much of the damage in each organ is related to
direct viral cytopathic effect and/or to secondary pro-
inflammatory and/or pro-thrombotic injury. In-depth
analyses of tissue samples from living patients and
post-mortem examinations are key to deciphering the
relative contribution of these events and guiding the
development of effective therapies.
SARS-CoV2 can be identified within each organ
through detection of its proteins and RNA. The specific
cell types infected can be determined by spatial profiling
or single cell analysis. Electron microscopy (EM) has
also been used to identify virions within tissue. Indeed,
human coronavirus was first described by virologist June
Almeida in 1967, then at St Thomas’Medical School in
London, through the use of negative staining electron
microscopy on human nasal and tracheal epithelial cells
grown in culture and infected with ‘nasal washings from
a patient with a cold’ [1]. Almeida and colleagues named
the new virus coronavirus, because of its appearance in
these original photographs, ‘recalling the solar corona’
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[2]. Since then, in several coronavirus outbreaks (SARS
[3], MERS [4], and the current SARS-CoV-2), intracel-
lular and extracellular structures with a corona have been
used to suggest the purported presence of virus in a vari-
ety of tissues (upper and lower respiratory tract, large
intestine, kidney, and macrophages), when they are in
fact showing structures associated with cell trafficking
pathways. Many of the observations have been made
on poorly preserved autolysed post-mortem tissues. In
addition, exposure to EM technique and interpretation
is limited in routine diagnostic histopathology practice
and largely confined to renal and neuromuscular pathol-
ogy. Therefore, intimate knowledge of ultrastructural
human cell substructures is not widespread amongst
pathologists. The advent of super-resolution micros-
copy, which allows near-EM resolution immunofluores-
cent imaging, has led to major advances in
understanding the normal cellular trafficking pathways
relevant to viral entry, replication, and release [5]. Diag-
nostic pathologists are not up to date with these
advances. Clathrin-coated vesicles, caveoli, and multi-
vesicular bodies have been misinterpreted as being cyto-
plasmic coronavirus particles because these structures
have the appearance of being coated with ‘spikes’
[6–9]. These are, in fact, part of normal cell trafficking
pathways. The confusion has been caused by a lack of
integration of basic science and virology into clinical
pathology, where there is limited appreciation of other
structures with ‘crowns’ and limited knowledge of the
effect of staining and processing on the visibility of the
coronavirus ‘crown’.
The aim of this review is to help in the differentiation
of the ‘normal’ cell from a coronavirus-infected cell, by
providing an update on the dynamic ultrastructure of cell
trafficking pathways, with a particular emphasis on
intracellular and extracellular features that could be con-
fused with virions. Additionally, the more typical fea-
tures of a coronavirus on routinely processed clinical
electron microscopic samples are described.
Ethics
Anonymised diagnostic electron micrographs were
reviewed randomly for good illustrations of the cell
trafficking structures. Electron microscopy samples
from human subjects were obtained from the Imperial
College Healthcare NHS Trust Tissue Bank (MREC
17/WA/0161) (approved project number R20012).
QEHB and GSTT/KCH: no specific ethics as not
patient identifiable.
Cell trafficking and secretory pathways as
ultrastructural ‘mimics’ of SARS-CoV-2
Proteins and other molecules, collectively termed cargo,
are transported around the cell in a highly orchestrated
manner, with membrane-bound vesicles as ‘carts’ and
the microtubular system as ‘tracks’ [10]. There are two
main sites of sorting and packaging of proteins and other
molecules in the cell: the endosome [11] and the outer
layer of the Golgi apparatus called the trans-Golgi network
(TGN) [12]. A third possible site of sorting, predominantly
in cells of haematopoietic lineage, occurs in the lysosomes
[13]. The endosome deals with proteins internalised by
endocytosis and from the TGN, whereas the Golgi deals
with proteins from the endoplasmic reticulum, endosomes,
and lysosomes. The endoplasmic reticulum (ER)–Golgi
intermediate complex (ERGIC) transports proteins from
the ER to the Golgi and returns proteins that fail quality
control back from the Golgi to the ER [14].
Endocytosis
Endocytosis is the process of transport of a ‘cargo’ from
the extracellular surface of the cell to its inside; the cargo
consists of extracellular ligands and their transmembrane
proteins, including soluble molecules, protein, and lipids.
Endocytosis takes place at the cell membrane by a number
of routes [15–17] (Figure 1), of which the two main path-
ways are clathrin-mediated endocytosis (Figure 2A) and
caveolin-mediated endocytosis (Figure 2A). Caveoli,
clathrin-coated pits (CCPs), and clathrin-coated vesicles
(CCVs) were identified over 50 years ago with the advent
of EM. Both pathways require the cell membrane to bend
and pinch off from the plasma membrane, leading to sin-
gle membrane-bound vesicles; this is achieved by exter-
nal coating of the vesicles with membrane-associated
proteins, followed by actin polymerisation and enzymatic
separation (scission) from the donor membrane [17,18].
Clathrin-mediated endocytosis starts with CCPs
60–120 nm in diameter [17], which are readily identified
by the clathrin scaffold on the surface facing the cell cyto-
plasm, which imparts a distinct bristle coat [19]. After
internalisation, the clathrin coat is removed from the
CCVs (Figure 2B). Multiple receptors, such as those for
insulin and transferrin, are involved with the clathrin-
mediated pathway [16,20]. Caveolin-mediated endocyto-
sis occurs via specialised lipid rafts that form 50–100 nm
flask-shaped invaginations (caveoli) of the plasma mem-
brane. Caveolin-rich lipid rafts initiate the process, with
cavin proteins coating the cytosolic side of the membrane
[16,20]. Other pathways are termed clathrin-independent
endocytosis and are not readily identified by EM.
The endolysosomal pathway
Upon internalisation, the cargo in the endocytic vesicle
enters a complex trafficking pathway. Some vesicles
are transported across the cell (transcytosis); this occurs
predominantly after caveolin-mediated endocytosis
[16,20,21]. Most endocytic vesicles are quickly targeted
to the early endosome (EE) (Figure 3), a sorting station,
where the fate of the cargo is determined. The exact
mechanism by which an EE forms is unclear; however,
the membrane volume is mainly derived from the fusion
of endocytic vesicles from all pathways [24]. EEs tend to
be peripherally placed in the cells, close to the plasma
membrane [24], and have a complex pleomorphic struc-
ture (Figure 3B), varying between cell types. The EE can
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have both thin tubular extensions approximately 60 nm
in diameter and bulbous areas 400 nm in diameter
with membrane invaginations (Figure 1). The membrane
invaginations in bulbous areas impart a multivesicular
appearance on transverse section (Figure 3A,C)
[25,26]. Proteins targeted for recycling are directed
to the tubular extensions, whereas the multivesicular
area is usually involved in sorting proteins towards
the degradation pathways, with the involvement of
ubiquitin [22,27].
Figure 1. Cell trafficking pathways. Endocytic entry to the cell is via clathrin-coated pits, caveoli or clathrin-independent endocytosis (not
shown, as not identifiable by EM). The ‘spikey’ clathrin coat (yellow dots) is removed from the clathrin-coated vesicles (CCVs) after endocy-
tosis. CCVs and caveoli-derived endocytic vesicles are incorporated into the early endosome (EE), which has tubular extensions and a bulbous
part in which there are microvesicles. CCVs predominantly bud off the EE; the contents are either recycled to the cell membrane or trans-
ported to the trans-Golgi network along microtubules (MT). The EE, moving along MTs, matures into the late endosome (LE), which is mostly
derived from the bulbous part of the EE and is termed a multivesicular body (MVB) containing intraluminal vesicles (ILVs). The MVBmay (1) be
transported along microtubules to the cell membrane and the ILVs released by exocytosis as exosomes; (2) fuse with a lysosome to form an
endolysosome or (3) fuse with an autophagosome to form an amphisome. Lysosomes contain enzymes for breakdown of the cargo. CCVs are
released from the lysosomal-derived structures (endolysosome, autolysosome) and transported to the Golgi apparatus for further sorting or
to the cell membrane for release by exocytosis. In addition, a clathrin coat is present on many of the intraluminal vesicles within the
endolysomal system, obtained during internalisation.
Figure 2. Endocytic pathways. (A) Glomerular mesangial cell with caveoli (arrows) and clathrin-coated pits (arrowheads). Scale
bar = 100 nm. (B) Podocyte containing clathrin-coated vesicles (arrows). Scale bar = 100 nm.
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The network of endosomal tubules can be remarkably
extensive [28] (Figure 3D). Endocytosed receptors are
recycled to the cell membrane [27] via a fast or slow
pathway [25,29]. Fast recycling involves direct transport
to the plasma membrane, whilst the slow route involves
a system of semiautonomous or interconnecting recy-
cling membrane pathways [23], together generally
termed the recycling endosomes (REs). REs are trans-
ported along microtubules to a perinuclear position,
where they cluster in the endocytic recycling compart-
ment adjacent to the microtubule-organising centre
(MTOC)/centriole [25]. They are involved in transport
to and from the TGN [30]. Recent evidence suggests that
cargo recycling is highly regulated, requiring endosomal
sorting complexes, and that several of these processes
are regulated by actin [29].
The bulbous areas of the EE containing the intralum-
inal invaginations mature into multivesicular bodies
(MVBs) or late endosomes (LEs). MVBs (Figure 3A,
C), recognised since the advent of EM, measure
100–1000 nm in diameter and contain intraluminal ves-
icles (ILVs) approximately 50–100 nm in diameter
[22,24]. ILVs are predominantly produced by a clathrin
coat mechanism [31]. Protein (cargo) tagged with ubi-
quitin is targeted to the MVB [22]. The MVB may fuse
with the cell membrane and release the ILVs as
exosomes into the extracellular environment (Figure 1)
[22], or may fuse with a lysosome, which contains
enzymes for degradation [22,32] (Figure 1). LEs/MVBs
may also fuse with autophagosomes (Figures 1 and
3E) to form an amphisome [33]. Autophagosomes
are formed during autophagy (Figure 1), a process
of degradation and recycling of cellular components.
In autophagy, an omegasome arises from the ER
[34] and forms a tubular structure, a phagophore
(Figure 1), which wraps around and encloses the
material to be degraded, forming the autophagosome
(Figure 1), which by virtue of this process has a dou-
ble membrane. Therefore, when an LE/MVB fuses
with an autophagosome, it may for a period have a
double membrane, prior to fusing with a lysosome
to form an autolysosome (Figure 1) [33,35]. Further
sorting of cargo occurs in the lysosome/lysosomal
fusion structures (Figure 1); proteins not for degrada-
tion are released as vesicles via clathrin pathways
[36,37] or by exocytosis [33].
The Golgi apparatus
The Golgi apparatus (Figures 1 and 3F) is a sorting
system for proteins from the ER, endosomes, and lyso-
somes. It is composed of a variable number of layers of
Figure 3. Cell trafficking structures. (A) Podocyte containing multivesicular bodies (arrows) and microtubular organisation centres (*). N,
nucleus. Scale bar = 500 nm. (B) Freeze etch electron micrograph on an early endosome illustrating the tubular network. The endosome is
visualised by low-density lipoprotein (LDL)-gold particles endocytosed for 5 min (gold particles are visualised as white spots). Reproduced
from [22] with permission. (C) Higher magnification of an overlapping field of panel A showing a multivesicular body (MVB) (arrowhead) con-
taining intraluminal vesicles (arrows) with a clathrin coat, giving a spikey appearance. A tubular process can be seen extending from theMVB.
Scale bar = 250 nm. (D) Network of long tubular endosomes in HeLa cells incubated for 5 min in 5 μg/ml brefeldin A. Reproduced from [23]
with permission. (E) An autolysgosome/amphisome (arrow) in a podocyte containing a mitochondrion (m) for degradation and vesicles with a
spikey clathrin coat. Scale bar = 100 nm. (F) Podocyte with a Golgi apparatus (g) with numerous cell trafficking microvesicles nearby. m,
mitochondrion; n, nucleus. Scale bar = 500 nm.
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cisternae. The layer nearest the ER receives vesicles con-
taining proteins and lipids from the ER and is known as
the cis-Golgi network (CGN) or the ERGIC. The layer
furthest away from the ER is the TGN, and collects,
sorts, and packages numerous molecules within vesicles
for transport to their final destination [12]. Clathrin and
other coated pits are involved in the secretion of vesicles
from the TGN [12,38].
Figure 4. Exocytosis/extracellular vesicles and other mimics. (A) Podocyte (P), glomerular basement membrane (#), and glomerular endothe-
lium (black arrow). There is an autolysosome/amphisome (arrowhead) (same as Figure 3E) and exosomes (white arrow). Extracellular vesicles
(split white arrow) are also seen within reduplicated subepithelial basement membrane (}). Scale bar = 500 nm. (B) Higher power of the exo-
cytotic vesicles in the boxed area in A. Plasma membrane (arrowhead), exosomes (black arrow), extracellular vesicles (split arrow), glomerular
basement membrane (#), and replicated subepithelial basement membrane (}). Scale bar = 250 nm. (C) Podocyte containing an autolyso-
some (arrowhead); some of the contents are granular (arrow). Similar granular material is seen outside the cell, having been exocytosed
(arrow in the box). Scale bar = 500 nm. (D) Higher power of the exocytosed membrane-bound vesicles (white arrow) from the boxed area
in C. Black arrow indicates plasma membrane. Scale bar = 100 nm. (E) Edge of a nucleus (N) near which nuclear pores (arrows) are forming
round structures with a granular texture and slightly spikey appearance. m, mitochondria. Scale bar = 250 nm. (F) Podocyte containing rough
endoplasmic reticulum (arrows) which could be confused with coronavirus due to the ‘spikey’ appearance of the ribosomal coat. Golgi appa-
ratus (g) and nucleus (N) are present. Scale bar = 250 nm. (G) Microvilli (black arrow) can be seen extending from the cell surface. Where cut
in transverse section (white arrow), they look similar to coronavirus, with a textured dotty interior and dense, slightly spikey outer layer.
Clathrin-coated vesicles (arrowheads) are present within the cytoplasm and have a similar appearance. Scale bar = 250 nm.
EM comparison of coronavirus and cell trafficking structures 5
© 2020 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd.
on behalf of The Pathological Society of Great Britain and Ireland. www.pathsoc.org
J Pathol 2020; 00: 000–000
www.thejournalofpathology.com
Exocytosis
Extracellular vesicles (Figure 4) comprise vesicles with
a membrane derived either from organelle membranes
(exosomes) or from the plasma membrane (microvesi-
cles) [25,39]. Exosomes can be formed by the fusion of
an MVB with the plasma membrane and release of the
ILV as exosomes. They measure 30–150 nm in diame-
ter, whereas microvesicles can measure 30–1000 nm in
diameter [40]. Extracellular vesicles contain cellular
proteins, RNA, and DNA, and can endocytosed by other
cells, allowing cross talk between cells [40,41].
Other potential ultrastructural coronavirus ‘mimics’
Another potential intracellular mimic is the nuclear pore.
The nuclear pore is a tubular structure that passes across
both nuclear membranes projecting into the nucleus and
cytoplasm either side, allowing the transport of proteins,
mRNA, tRNA, and ribosome subunits. Nuclear pores
are 80–120 nm in diameter, with an inner diameter of
approximately 40 nm [42]. Because they project beyond
the nuclear membrane, they may appear as a round struc-
ture distinct from the nucleus on TEM (Figure 4E). The
rough ER (Figure 4F) has ribosomes attached to the
membrane forming projections that have also been
confused with the spikes of coronavirus [9].
Transverse sections through microvilli may be con-
fused with extracellular coronavirus. Microvilli are cel-
lular membrane protrusions that are involved in a wide
variety of cellular functions. They are made of a single
plasma membrane and inside cytoplasm with microfila-
ments (e.g. actin and others) but no organelles. Micro-
villi measure 50–100 nm in diameter on cross-section
and are covered with a glycocalyx, which can show
spiky extensions on EM, giving the appearance of a
‘crown’ (Figure 4G) [43,44].
Coronavirus structure, replication, and
ultrastructural appearances
Much of our current understanding of cell infection with
SARS-CoV-2 relies on previous work done with SARS-
CoV, the agent that caused the SARS outbreak in
2002–2004. The genome sequences are 79.5% identical,
with 86% non-structural protein sequence identity; it is
thus considered highly likely that the replication process
of both viruses is similar [45].
Both SARS-CoV and SARS-CoV-2 are enveloped
RNA viruses. Their membrane is acquired from host
membranes and therefore has a similar ultrastructure,
i.e. a lipid bilayer. Viral membrane (M), envelope (E),
and spike (S) proteins are embedded within this mem-
brane when the virus is formed in host cells, with the S
proteins projecting from the surface to appear on nega-
tive staining EM as a crown (corona) [46,47]. The nucle-
ocapsid, consisting of the viral RNA and associated with
nucleocapsid (N) protein, is located within this envelope
(Figure 5).
Coronaviruses all induce similar replicative structures
within cells. They replicate in the cytoplasm, in conjunc-
tion with modified endomembranes derived from the
endoplasmic reticulum forming the viral replication
organelles (ROs) (Figure 6B,C), without nuclear
involvement [45,49]. Figure 5 depicts the intracellular
viral replication pathway, which we describe in more
detail here. The initiation of cell entry involves binding
of the receptor binding domain of the S protein to the
protease domain of angiotensin-converting enzyme
2 (ACE2), which acts as a receptor [50–54].Whilst exact
mechanisms for cell entry of SARS-CoV-2 are not yet
known, they are likely to be similar to SARS-CoV, in
which clathrin-dependent [45] and clathrin-independent
[55] endocytosis pathways are used; the pathway
involved may vary between cell types [56]. Using a
SARS-CoV-2 pseudovirus model, cell entry was found
to be mainly by clathrin-dependent endocytosis [51].
The endocytosed virus enters the endocytic pathways
of the cell and is delivered to an endosome [57], resulting
in the intact virion within an endocytic clathrin-coated
vesicle. The virion envelope fuses with the endocytic
vesicle/EE membrane, releasing the uncoated viral
nucleocapsid into the cytoplasm.
Translation of the viral genomic RNA results in two
polyproteins that are proteolytically cleaved to form
non-structural proteins (NSPs), which induce the RO
[45]. The RO comprises convoluted membranes, double
membrane vesicles (DMVs) [45,58–61], and small open
double membrane spherules, all derived from, and
remaining connected to, the ER, which may include zip-
pered areas [45,62]. DMVs are common to all corona-
viruses, whilst the other structures may not be [45].
The replication transcription complexes (RTCs), the
virus replication machinery, produced by transcription
of the viral genomic RNA, are anchored to these mem-
branous structures [60,61]. The RTCs facilitate further
transcription of a subset of sub-genomic RNA, which
occurs within the DMVs. The sub-genomic RNA
encodes for 15–16 viral structural and accessory pro-
teins. Translation of the membrane structural and acces-
sory proteins occurs in the ER, whilst translation of the N
proteins occurs in the cytoplasm on free ribosomes [48].
Complete copies of the genomic RNA are replicated
from a negative copy of the genomic RNA in the cyto-
plasm [48]. The translated membrane structural pro-
teins move along the ER secretory pathway to the
ERGIC, where partial assembly of the viral envelope
proteins occurs [48]. The viral genomes encapsidated
by N proteins butt into the ERGIC partial viral enve-
lope, forming a bud in the ERGIC, which pinches off,
resulting in virions within cisternal spaces derived from
the Golgi/ER [48,63]. The virions within vacuoles are
transported to the cell membrane, using the usual secre-
tory route of the ER/Golgi complex [64], and released
by exocytosis [48,65].
Ultrastructural viral features have been described
based on images from infected cultured cells, where
they measure 60–140 nm in diameter with spikes
9–12 nm in length [64], the spikes being seen on
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negatively stained specimens. Coronaviruses at different
stages of development can be found in membrane-bound
vacuoles within the cytoplasm of the infected cell [66],
or outside the cell, near the plasma membrane [64]
(Figure 6C–F). The helical viral nucleocapsid produces
characteristic black dots within the virion [9,67,68]
(Figure 6F).
Transmission EM on human tissue to identify virus:
how do you recognise a wolf in sheep’s clothing?
EM of diagnostic tissue sections is not an easy option for
the identification of virus and there is limited experience
in this field: The subset of histopathologists who use EM
are not usually required to identify viruses, whereas
virologists, who rarely use EM or use EM only on opti-
mally preserved viral or cell preparations with different
techniques (e.g. negative staining), are not used to
poorly preserved and suboptimally handled diagnostic
tissue samples [66,69,70]. Most EM related to corona-
viruses is undertaken in animal/veterinary research facil-
ities, with little translation into the clinical diagnostic
field. In addition, there are differences between the ultra-
structural features of infected tissue culture cells and
infected cells in vivo [67]. For example, DMVs and
nucleocapsid may be harder to identify in post-mortem
and surgical samples [67] and may only be present at
very low quantity. Taking all of these factors into
account, it is perhaps not surprising that errors in inter-
pretation of clinical EM samples have been made both
in the current coronavirus outbreak [6–9] and in previous
outbreaks affecting humans [3,4].
Figure 5. Viral replication pathways. SARS-CoV-2 binds ACE2 on the cell membrane and enters the cell via clathrin-mediated endocytosis.
The virion membrane fuses with the endocytic membrane with release of the nucleocapsid (NC) into the cytoplasm. The free genomic RNA
is then translated and cleaved to non-structural proteins, which induce the formation of the replication organelle (RO), comprising endoplas-
mic reticulum (ER)-derived membranous structures in which the replication transcription complex (RTC) proteins are embedded. Replication
of genomic and subgenomic (sg) RNA, via a negative sense RNA, occurs in the replication organelle. Translation of the nucleocapsid proteins
(N) occurs on cytosolic ribosomes, and translation of the envelope (E), membrane (M), and spike (S) proteins occurs on rough ER, with inser-
tion of these proteins into the ER membrane. The N proteins associate with the genomic RNA to form the nucleocapsid, which then buds into
the ER–Golgi intermediate complex (ERGIC). The resultant vesicle buds off into the ERGIC, forming a virion with the envelope acquired from
the ERGIC membrane in which the E, M, and S proteins are embedded. Virions are transported to the cell surface in membrane-bound
vacuoles and released by exocytosis. Adapted from [48,49].
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The type of tissue and processing pathways can alter
the size and appearance of the virus. SARS-CoV-2 is
smaller when tissue is taken from a formalin-fixed,
paraffin-embedded block, averaging 75 nm, compared
with 105 nm in diameter when tissue is processed
directly for electron microscopy [67]. Using routine
diagnostic EM processing techniques, intracellular virus
lacks prominent spikes, whilst they may be visible on
extracellular virus [67]. This is because the appearance
of surface glycoproteins can be lost during routine pro-
cessing, and the spike is a glycoprotein [46,71]. Tannic
acid pretreatment during processing can enhance visual-
isation of the spikes [72].
Infected cells can be sparse and therefore unsampled
in small diagnostic tissue samples, contrary to optimised
cell cultures. Intracellular trafficking structures can be
easily confused with the virus. To improve certainty that
a structure is of viral origin, immunoelectron micros-
copy and ultrastructural in situ hybridisation can be per-
formed [72]. Immunoelectron microscopy involves a
primary antibody to a specific viral protein, detected
with a secondary antibody labelled with gold, which is
electron-dense. Standard glutaraldehyde and parafor-
maldehyde fixatives with uranyl acetate and lead citrate
staining may be compatible with this technique,
although this depends on the antibody. However,
osmium tetroxide post-fixation may interfere [73]. In
immunoelectron microscopy experiments, a much lower
percentage of glutaraldehyde is usually used to optimise
the antigen. Tissue embedded in acrylic resin rather than
the standard epoxy resin will result in better antigen
preservation, related to low-temperature polymerisation
[73]. Ultrastructural in situ hybridisation uses negative
sense riboprobes and is best accomplished on tissues in
a hydrophilic acrylic resin [72]. However, these tech-
niques are complicated and not usually available in a
diagnostic histopathology department.
While we await the results of these complex investiga-
tions, the following points may help to establish if an
intra- or extra-cellular structure likely represents a virus.
• Virally infected cells may not be numerous; in gen-
eral, beware of viral-like structures that are present in
all the cells visualised. Compare any structures with
Figure 6. SARS CoV-2-infected Vero E6 cells. (A) Control mock-infected (bar = 1 μm) and (B–F) infected with SARS-CoV-2. Cells were
infected at a multiplicity of infection of 0.1 and fixed 48 h post-infection in 3% glutaraldehyde in sodium cacodylate buffer. (B) Infected cells
contain dilated membrane-bound structures in the cytoplasm – the replication organelle (dotted oval) – which may aid detection of infected
cells at low power. This may be less conspicuous in biopsy and post-mortem specimens. Scale bar = 2 μm. (C) The replication organelle derives
from the endoplasmic reticulum and is largely composed of double-membrane vesicles (black arrows). An elongated membrane-bound struc-
ture containing virions with a ‘peas in a pod’ appearance (white arrow) is present. Scale bar = 200 nm. (D) Numerous virions are seen as small
round particles within membrane-bound vacuoles (white arrows) in the cytoplasm and extracellularly closely associated with the microvilli
(black arrows). Scale bar = 600 nm. (E) Higher magnification showing the extracellular virions (arrows) with a dotty salt-and-pepper appear-
ance due to the internal nucleocapsid, amongst microvilli (arrowheads). The ‘crown’ is not apparent in this preparation. Scale bar = 100 nm.
(F) Intracellular virions (arrows) within single membrane-bound vacuoles. The nucleocapsid provides the characteristic dots within the virion
and the phospholipid bilayer of the viral envelope similar to the vacuole membrane can just be distinguished. No definite crown (spikes) are
seen, which is usually the case on intracellular virus unless special processing is undertaken. Scale bar = 50 nm.
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a negative control matched sample (same tissue, simi-
lar disease, with identical sample processing) from
patients known not to be infected.
• Consider biological plausibility when considering
which cell types might be infected; ACE2 acts as the
receptor for cell entry by SARS-CoV-2 [54]. ACE2
is expressed on arterial and venous endothelial cells
throughout the body [54] (with the exception of liver
sinusoidal cells and glomerular endothelial cells
[74,75]), arterial smooth muscle cells, ciliated epithe-
lial and goblet cells in the upper airways, type I and
II pneumocytes in the lung, biliary epithelial cells
[76,77], podocytes and parietal epithelial cells [77],
proximal renal tubular epithelial cells, gut epithelial
and smooth muscle cells, cardiac myocytes, epicardial
adipocytes and fibroblasts, pigmented epithelial cells,
rod and cone photoreceptor cells in the eyes, and neu-
rones and glial cells in the central nervous system [78].
Molecular and/or immunohistochemical investiga-
tions have provided evidence for SARS-CoV-2 in a
limited number of cell types. The highest levels of
viral protein and/or RNA are detected in alveolar
pneumocytes and ciliated bronchial epithelial cells
[67,79–84]. In a subset of patients deceased with
COVID-19, lower amounts of virus have also been
identified in the epithelium of the gastrointestinal tract
[82], biliary epithelium [82], renal tubular epithelium
[82,83], glomerular cells [84], and alveolar macro-
phages and alveolar capillary endothelial cells [82].
In other cases, viral RNA has been found in tissues
without data on specific cell types infected: heart
[79,82,84,85], skeletal muscle [82], lymph nodes
[79], and brain [83]. In patients with skin lesions, the
virus has been identified in endothelium of the vessels
within the skin [86].
• Low-power magnification may help to identify the
sparse infected cells. The viral replicative organelle
results in an excess of membrane-bound spaces within
the cell compared with neighbouring cells which may
be visible at low power (Figure 6B). Based on molec-
ular data, infected cells tend to be clustered [82]. If
identified, the RO is a useful clue to viral origin.
• In cases where the RO is only present in low quantity,
medium-power magnification may help to identify the
sparse infected cells by the identification of accumu-
lating virion in membrane-bound vacuoles
(Figure 6D).
• Intracellular virus is found in membrane-bound struc-
tures, mostly in the cisternae of the ER–Golgi after
replication and membrane-bound vacuoles transport-
ing the virions to the cell surface and briefly in endo-
cytic vesicles after cell entry; intracytoplasmic
structures with a ‘corona’ directly projecting into the
cytoplasm (rather than into a cisternal space) are likely
CCVs [7], derived from endocytosis, from the TGN or
from endosomes/endolysosomes.
• Cross-sections through the viral nucleocapsid result in
black dots within the viral particle (Figure 6E,F)
[9,67]. A membrane-bound structure containing
virus-sized structures but without these internal dots
is likely a normal endolysomal structure, most com-
monly an MVB, but could also be an endolysosome,
amphisome or autolysosome.
• Infected cells tend to have both intracellular and extra-
cellular virus (Figure 6D), as the virus will be
replicating
• Extracellular virus, often with spikes as well as the
characteristic nucleocapsid dots, is seen along the cell
membranes and amongst cilia/microvilli [67].
• Both intracellular and extracellular virus show relative
uniformity in size compared to endosomal structures.
Summary
Cells have a system for sorting and transporting ‘cargo’,
centred on the endosomal network, with bidirectional
connections between the cell membrane, lysosomes,
Golgi, and ER. The endosomal network is a system of
tubules and microvesicles which derive from the early
endosome formed from endocytic vesicles, which
matures to the late endosome/multivesicular bodies. At
the ultrastructural level, these structures are being con-
fused with a coronavirus when they have a coat which
gives a spikey ‘crown-like’ appearance. A coat, most
commonly clathrin, is required to allow membranes to
bend to form vesicles, so CCVs are fairly ubiquitous
throughout all cell types. However, the spikes on corona-
virus virions are not readily identified on routinely pre-
pared TEM samples; inner ‘dots’ representing
nucleocapsid are the more characteristic feature in tissue
samples. A useful clue to identifying infected cells is the
RO, composed of large numbers of membranous struc-
tures seen on a low to medium power scan. Intracellular
coronavirus is found singly or in groups within
membrane-bound vacuoles and is unlikely to be found
as an isolated virion in direct contact with the cytoplasm,
in contrast to a clathrin-coated vesicle.
In conclusion, it is possible in the majority of cases to
discriminate coronavirus from normal intracellular
structures. A requirement for early collaboration
between animal virus researchers and diagnostic clinical
facilities is identified for future outbreaks of a novel
virus to prevent interpretation errors and accelerate
research.
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